Atlas Trials

Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica

Clinical trial NCT04799262 · COMPLETED

Trial details

NCT number
NCT04799262
Sponsor
RenJi Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Polymyalgia RheumaticaEffect of DrugSafety Issues
Start date
2021-01-01
Primary completion
2022-03-16
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.